Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics
Pyrrole is widely known as a biologically active scaffold which possesses a diverse nature of
activities. The combination of different pharmacophores in a pyrrole ring system has led to …
activities. The combination of different pharmacophores in a pyrrole ring system has led to …
Pyrrole: A Decisive Scaffold for the Development of Therapeutic Agents and Structure‐Activity Relationship
An overview of pyrroles as distinct scaffolds with therapeutic potential and the significance of
pyrrole derivatives for drug development are provided in this article. It lists instances of …
pyrrole derivatives for drug development are provided in this article. It lists instances of …
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays
JB Baell, GA Holloway - Journal of medicinal chemistry, 2010 - ACS Publications
This report describes a number of substructural features which can help to identify
compounds that appear as frequent hitters (promiscuous compounds) in many biochemical …
compounds that appear as frequent hitters (promiscuous compounds) in many biochemical …
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
J Chen, J **e, Z Jiang, B Wang, Y Wang, X Hu - Oncogene, 2011 - nature.com
We recently reported that shikonin and its analogs were a class of necroptotic inducers that
could bypass cancer drug resistance. However, the molecular targets of shikonin are not …
could bypass cancer drug resistance. However, the molecular targets of shikonin are not …
Copper nanoparticles as inexpensive and efficient catalyst: A valuable contribution in organic synthesis
NK Ojha, GV Zyryanov, A Majee, VN Charushin… - Coordination Chemistry …, 2017 - Elsevier
Copper nanoparticles have been explored as a new class of heterogeneous catalyst in
various chemical transformations. This review surveys the most useful organic …
various chemical transformations. This review surveys the most useful organic …
[HTML][HTML] Current ARTs, virologic failure, and implications for AIDS management: a systematic review
FET Foka, HT Mufhandu - Viruses, 2023 - mdpi.com
Antiretroviral therapies (ARTs) have revolutionized the management of human
immunodeficiency virus (HIV) infection, significantly improved patient outcomes, and …
immunodeficiency virus (HIV) infection, significantly improved patient outcomes, and …
HIV-1 entry and membrane fusion inhibitors
HIV-1 (human immunodeficiency virus type 1) infection begins with the attachment of the
virion to a host cell by its envelope glycoprotein (Env), which subsequently induces fusion of …
virion to a host cell by its envelope glycoprotein (Env), which subsequently induces fusion of …
Entry inhibitors: efficient means to block viral infection
The emerging and re-emerging viral infections are constant threats to human health and
wellbeing. Several strategies have been explored to develop vaccines against these viral …
wellbeing. Several strategies have been explored to develop vaccines against these viral …
Concise and versatile multicomponent synthesis of multisubstituted polyfunctional dihydropyrroles
Q Zhu, H Jiang, J Li, S Liu, C **a… - Journal of Combinatorial …, 2009 - ACS Publications
Tetra-and pentasubstituted polyfunctional dihydropyrroles have been concisely synthesized
in high yields by two different processes of the one-pot multicomponent reactions (MCRs) of …
in high yields by two different processes of the one-pot multicomponent reactions (MCRs) of …
Inhibition of HIV-1 by fusion inhibitors
D Eggink, B Berkhout… - Current pharmaceutical …, 2010 - ingentaconnect.com
The envelope glycoprotein complex (Env) is responsible for entry of the human
immunodeficiency virus type 1 (HIV-1) into cells by mediating attachment to target cells and …
immunodeficiency virus type 1 (HIV-1) into cells by mediating attachment to target cells and …